Brevundimonas vesicularis keratitis after laser in situ keratomileusis

Jesse S. Pelletier, Takeshi Ide, Sonia H Yoo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A 45-year-old woman developed a corneal infiltrate 14 months after laser in situ keratomileusis (LASIK) enhancement in the left eye. The LASIK flap was lifted, scraped, and irrigated with fortified vancomycin and ceftazidime. Scraped samples were cultured and grew Brevundimonas vesicularis. The patient remained on topical ceftazidime until improvement was noted and was then switched to topical levofloxacin. The keratitis resolved on antibiotic agents with strong gram-negative coverage and a steroid. To our knowledge, this is the first report of a B vesicularis ocular infection. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.

Original languageEnglish
Pages (from-to)340-343
Number of pages4
JournalJournal of Cataract and Refractive Surgery
Volume36
Issue number2
DOIs
StatePublished - Feb 1 2010

Fingerprint

Laser In Situ Keratomileusis
Ceftazidime
Keratitis
Lasers
Eye Infections
Levofloxacin
Disclosure
Vancomycin
Steroids
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Surgery

Cite this

Brevundimonas vesicularis keratitis after laser in situ keratomileusis. / Pelletier, Jesse S.; Ide, Takeshi; Yoo, Sonia H.

In: Journal of Cataract and Refractive Surgery, Vol. 36, No. 2, 01.02.2010, p. 340-343.

Research output: Contribution to journalArticle

@article{ca8e933f4a6542009fcd3bd12736938d,
title = "Brevundimonas vesicularis keratitis after laser in situ keratomileusis",
abstract = "A 45-year-old woman developed a corneal infiltrate 14 months after laser in situ keratomileusis (LASIK) enhancement in the left eye. The LASIK flap was lifted, scraped, and irrigated with fortified vancomycin and ceftazidime. Scraped samples were cultured and grew Brevundimonas vesicularis. The patient remained on topical ceftazidime until improvement was noted and was then switched to topical levofloxacin. The keratitis resolved on antibiotic agents with strong gram-negative coverage and a steroid. To our knowledge, this is the first report of a B vesicularis ocular infection. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.",
author = "Pelletier, {Jesse S.} and Takeshi Ide and Yoo, {Sonia H}",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.jcrs.2009.07.050",
language = "English",
volume = "36",
pages = "340--343",
journal = "Journal of Cataract and Refractive Surgery",
issn = "0886-3350",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Brevundimonas vesicularis keratitis after laser in situ keratomileusis

AU - Pelletier, Jesse S.

AU - Ide, Takeshi

AU - Yoo, Sonia H

PY - 2010/2/1

Y1 - 2010/2/1

N2 - A 45-year-old woman developed a corneal infiltrate 14 months after laser in situ keratomileusis (LASIK) enhancement in the left eye. The LASIK flap was lifted, scraped, and irrigated with fortified vancomycin and ceftazidime. Scraped samples were cultured and grew Brevundimonas vesicularis. The patient remained on topical ceftazidime until improvement was noted and was then switched to topical levofloxacin. The keratitis resolved on antibiotic agents with strong gram-negative coverage and a steroid. To our knowledge, this is the first report of a B vesicularis ocular infection. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.

AB - A 45-year-old woman developed a corneal infiltrate 14 months after laser in situ keratomileusis (LASIK) enhancement in the left eye. The LASIK flap was lifted, scraped, and irrigated with fortified vancomycin and ceftazidime. Scraped samples were cultured and grew Brevundimonas vesicularis. The patient remained on topical ceftazidime until improvement was noted and was then switched to topical levofloxacin. The keratitis resolved on antibiotic agents with strong gram-negative coverage and a steroid. To our knowledge, this is the first report of a B vesicularis ocular infection. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.

UR - http://www.scopus.com/inward/record.url?scp=75349107241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75349107241&partnerID=8YFLogxK

U2 - 10.1016/j.jcrs.2009.07.050

DO - 10.1016/j.jcrs.2009.07.050

M3 - Article

C2 - 20152619

AN - SCOPUS:75349107241

VL - 36

SP - 340

EP - 343

JO - Journal of Cataract and Refractive Surgery

JF - Journal of Cataract and Refractive Surgery

SN - 0886-3350

IS - 2

ER -